Blog Posts

Exclusive: HRSA Asking Hospitals About 340B Patient Definition, 340B Savings, and Using 340B at Child Sites

HRSA
HRSA has sent multiple hospitals letters asking about patient eligibility for 340B drugs, use of 340B savings, and 340B compliance in offsite outpatient locations.

UPDATED Thursday March 2, 2023, 12:30 p.m. EDT to include comment from HRSA.

The U.S. Health Resources and Services Administration has asked multiple hospitals to explain how they determine patient eligibility for 340B drugs, how they define, track,

Read More »

Verity Presents: 340B Outlook from Capitol Hill and the States

SPONSORED CONTENT

Will you be attending the 340B Winter Coalition Conference in San Diego? Start your week with the latest developments in the 340B program. This year, Verity Solutions will be hosting a panel discussion on Monday morning with some of the most respected long-term

Read More »

Feds Considering Asking Full Appeals Court to Rehear Case Over AstraZeneca, Novo Nordisk, and Sanofi’s 340B Contract Pharmacy Policies

Third Circuit Court
HHS might ask the full U.S. Third Circuit Court of Appeals to rehear a a lawsuit over AstraZeneca, Novo Nordisk, and Sanofi’s 340B contract pharmacy policies.

The federal government may ask all 14 judges on the U.S. Third Circuit Court of Appeals to review a three-judge panel’s unanimous January opinion upholding AstraZeneca, Novo Nordisk, and Sanofi’s restrictions on 340B pricing when their drugs are

Read More »

Senate Democratic Whip Durbin: 340B Hasn’t Cut Pharma Profits Dramatically

Durbin
340B "hasn’t really cut the profits of the pharmaceutical companies dramatically,” U.S. Senate Majority Whip Dick Durbin (D-Ill.) said during a visit to a Chicago community health center.

The 340B program “is a really successful program and it hasn’t really cut the profits of the pharmaceutical companies dramatically,” U.S. Senate Majority Whip Dick Durbin (D-Ill.) said Friday during a visit to a Chicago-based community health center.

Read More »

Arkansas 340B Contract Pharmacy Law “Trespassed on Exclusively Federal Turf,” PhRMA Tells Appeals Court

US Eighth Circuit Court of Appeals
Arkansas's 340B contract pharmacy law "impermissibly trespassed on exclusively federal turf,” PhRMA told a federal appeals court in St. Louis.

Pharmaceutical Research and Manufacturers of America asked a U.S. appeals court in St. Louis, Mo. last week to strike down Arkansas’s first-of-its-kind 340B contract pharmacy law, arguing that it intrudes on the 340B statute and frustrates Congress’ intent

Read More »

340B Compliance Issues Requiring Repayment to Manufacturers

SPONSORED CONTENT

Resolving 340B noncompliance can be a time-consuming task for 340B participants — and one of the greatest challenges in managing a 340B program. This guide outlines the five steps to successfully navigate resolving compliance issues requiring repayment to manufacturers, from discovery to resolution, and includes a solution to help streamline the refund process.

Step #1: Discovering

Read More »

Judge Pauses PhRMA’s 340B Administrative Dispute Resolution Lawsuit

US District Court Baltimore
A federal district judge in Baltimore has paused PhRMA's lawsuit challenging the current 340B program administrative dispute resolution process.

A federal district judge in Baltimore, Md., yesterday stayed the brand drug industry’s lawsuit challenging the December 2020 340B program administrative dispute resolution final rule.

Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human

Read More »

340B Report Publisher and CEO: Is Hospital Transparency the Key to a Grand Bargain on 340B?

Handshake
Could hospitals' acceptance of 340B reporting requirements help end the fight over limits on 340B contract pharmacy and encroachment on providers’ 340B savings, 340B Report Publisher and CEO Ted Slafsky asks.

Could ending the fights over limits on 340B contract pharmacy and encroachment on providers’ 340B savings hinge on hospitals accepting 340B reporting requirements? 340B Report Publisher and CEO Ted Slafsky raises that provocative question in his monthly column

Read More »

One-Third of Americans Lack a Source of Primary Care and Health Centers Can Close the Gap, Says Report

NACHC
Almost one-third of Americans lack access to a usual source of primary care, the National Association of Community Health Centers says in a new report.

More than 100 million Americans—almost one-third of the population, and many of them children—lack access to a usual source of primary care due to a shortage of providers in their community, leading to delays in care, poorer health

Read More »

Key Lawmaker Introduces Bill to Protect NY Health Centers and Clinics from “Hundreds of Millions” in Lost 340B Savings

New York state capitol
A bill has been introduced in New York State to repeal the April 1 shift of state Medicaid managed care pharmacy benefits to Medicaid fee for service.

The chair of the New York Senate health committee has introduced legislation to repeal the April 1 shift of state Medicaid managed care pharmacy benefits to Medicaid fee for service. The state’s 340B health centers and Ryan White

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer